Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Videos

The health economics outcomes research specialist at UCB talked about a retrospective analysis assessing the persistence of fenfluramine (Fintepla) in Dravet syndrome over 12 months, compared with valproate and levetiracetam. [WATCH TIME: 4 minutes] 


A Real-World Look at the Prolonged Efficacy of Fenfluramine in Dravet Syndrome: Derek Ems, MPH, CPHQ

Articles

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of the American Epilepsy Society.

NeurologyLive® Brain Games: December 10, 2023

Neurology News Network for the week ending December 9, 2023. [WATCH TIME: 3 minutes]

Concomitant ASM Dosages With Stiripentol, FDA Pushes Givinostat Decision Back, Soticlestat Improves Caregiver Satisfaction

While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.

Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches

, has been with the team since October 2019. Follow him on Twitter 

The system vice chair for the department of neurology at Allegheny Health Network talked about the latest preventive and acute treatment options for patients with migraine as well as the progress of research in recent months. [WATCH TIME: 3 minutes] 

Looking Back on the Latest Advancements in Acute Migraine Treatment: Andrea S. Synowiec, DO, FAAN

Division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center.

The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center talked about the impact of ongoing seizures in patients with drug-resistant epilepsy and the importance of education for emerging opportunities in epilepsy care. [WATCH TIME: 3 minutes] 

Emphasizing Patient Conversations and Treatment Opportunities for Seizure Management: Danielle Becker, MD, MS, FAES

The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center discussed the profound repercussion of ongoing seizures for patients with epilepsy which is to be presented at AES 2023 in SK Life Science’s symposium. [WATCH TIME: 5 minutes] 

Exploring the Hidden Burdens of Persistent Seizures for Patients: Danielle Becker, MD, MS, FAES

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

Narcolepsy

NMOSD

Ataxia

Parkinson Disease

AES 2023

AANEM 2023

CTAD 2023

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

The News Network video series features a variety of clinicians providing updates on the major data and paradigm-affecting updates from societal meetings and conferences focused on patients with neurologic diseases.

1rem

ACTRIMS 2020: Post-Conference Perspectives

ACTRIMS 2020 News Network: CLARITY Study on Relapsing Multiple Sclerosis

ACTRIMS 2020 News Network: Updated Data From the CLARITY Study

ACTRIMS 2020 News Network: EXPAND Study on Relapsing MS

ACTRIMS 2020 News Network: Effect of Disease Duration in the EXPAND Study 

ACTRIMS 2020 News Network: OPERA I/II Trials on Relapsing MS

ACTRIMS 2020 News Network: 6-Year Data With Ocrelizumab

ACTRIMS 2020 News Network: APLIOS Bioequivalence Study on Relapsing MS

ACTRIMS 2020 News Network: B-Cell Depletion in the Phase 2 APLIOS Study  

ACTRIMS 2020 News Network: Updated Recommendations for Standardized MRI Protocol in MS

ACTRIMS 2020 News Network: Standardized MRI Protocol for MS 

ACTRIMS 2020 News Network: An Overview of Other Exciting Data

Investigators caution health care providers to consider specific risks of severe COVID-19 infection before initiating this therapy.

Immunosuppressive DMTs Associated With Longer COVID-19 Hospitalization in Patients With Multiple Sclerosis